Akso Health Group ADR (8HX)
FSX
0.6050
0.00 (0.00%)
Closed
Sep 25, 2026
Day's Range
0.59500.6050
52 wk Range
0.52502.14
Financial Statements - 8HX - Akso Health Group ADR
Revenue
13.83M▼ 6.4%
Net Income
-18.71M▲ 86.2%Net Margin -135.3%
EBITDA
15.07M▼ 90.6%
Free Cash Flow
-188.45M▼ 18527.4%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 13.83M | 14.77M | 2.41M | 13.18M | 5.12M | 0 |
| Cost of Goods | 13.84M | 15.05M | 2.29M | 11.91M | 4.60M | 0 |
| Gross Profit | -11.31K | -281.52K | 122.13K | 1.26M | 517.02K | 0 |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -4M | -3.92M | -8.63M | -14.26M | -2.09M | -1.78M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -16.70M | -162.34M | -453.75K | 1.20M | -638.93K | -44.49K |
| Pre Tax Income | -20.70M | -166.27M | -9.09M | -13.06M | -3.42M | -3.66M |
| Income Tax | -1.98M | -30.80M | 24.98K | 17.54K | 79.30K | 0 |
| Net Income | -18.71M | -135.46M | -9.51M | -1.24M | -14.39M | -29.75M |
| EPS Basic | -0.03 | -0.48 | -0.21 | -0.06 | -0.84 | -2.13 |
| EPS Diluted | -0.03 | -0.48 | -0.21 | -0.06 | -0.84 | -2.13 |
| Basic Shares Outstanding | 722.70M | 285.09M | 47.17M | 22.86M | 16.97M | 13.90M |
| Diluted Shares Outstanding | 722.70M | 285.09M | 47.17M | 22.86M | 16.97M | 13.90M |
| Ebit | -4M | -3.92M | -8.63M | -14.26M | -2.73M | -1.82M |
| Ebitda | 15.07M | 160.60M | -8.04M | -15.40M | -2.09M | -1.82M |
| Net Income Continuous Operations | -18.71M | -135.46M | -9.11M | -13.08M | -3.50M | -3.66M |
| Minority Interests | 44.57K | 491.76K | 57.79K | -112.49K | -1.33K | 0 |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
